ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, and FyoniBio GmbH, a contract development organization for biopharmaceuticals, today announced they have entered into a technology licensing agreement.
Under the agreement, FyoniBio gains worldwide, non-exclusive commercial rights for application of ProteoNic technology in its proprietary CHOnamite
